製品名:2-Methylpiperazine

IUPAC Name:2-methylpiperazine

CAS番号:109-07-9
分子式:C5H12N2
純度:98%
カタログ番号:CM120079
分子量:100.17

包装単位 有効在庫 価格(USD) 数量
CM120079-100g in stock ŢNJ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:109-07-9
分子式:C5H12N2
融点:-
SMILESコード:CC1NCCNC1
密度:
カタログ番号:CM120079
分子量:100.17
沸点:
MDL番号:MFCD00005954
保管方法:

Category Infos

Piperazines
Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.
Fuel Cell Materials
Fuel Cells is a highly efficient, clean and renewable energy technology with many advantages such as low emissions, high efficiency, quiet operation and flexibility. They can use many different fuels, such as hydrogen, methanol, natural gas and biomass, making them highly adaptable and flexible. Fuel cell materials are essential components in the construction and operation of fuel cells, which are devices that convert chemical energy from fuels into electrical energy through an electrochemical process. There are several types of fuel cells, such as proton exchange membrane fuel cells (PEMFCs), solid oxide fuel cells (SOFCs), and molten carbonate fuel cells (MCFCs), each requiring different materials for their functioning.

Column Infos

Fenebrutinib
Roche’s investigational drug, Fenebrutinib has shown brain penetration and significant reduction in lesions in patients with relapsing multiple sclerosis (MS) from the recent release of new data from Phase II FENopta study. Fenebrutinib is a potent and highly selective Bruton’s tyrosine kinase (BTK) inhibitor, and currently the only reversible inhibitor being tested in Phase III MS trials. BTK inhibitor is involved in key pathological features of MS, including B-cell development and activation.